PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
BIMI International Medical Inc. (BIMI)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS05552Q1031
CUSIP05552Q103
SectorHealthcare
IndustryPharmaceutical Retailers

Highlights

Market Cap$22.13M
EPS-$6.39
Revenue (TTM)$12.63M
Gross Profit (TTM)$4.60M
EBITDA (TTM)-$6.83M
Year Range$0.51 - $4.13
Target Price$12.50
Short %1.11%
Short Ratio1.88

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds to compare with BIMI

BIMI International Medical Inc.

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in BIMI International Medical Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-100.00%0.00%100.00%200.00%300.00%400.00%OctoberNovemberDecember2024FebruaryMarch
-99.99%
379.92%
BIMI (BIMI International Medical Inc.)
Benchmark (^GSPC)

S&P 500

Returns By Period

BIMI International Medical Inc. had a return of -23.29% year-to-date (YTD) and 211.11% in the last 12 months. Over the past 10 years, BIMI International Medical Inc. had an annualized return of -32.43%, while the S&P 500 had an annualized return of 10.89%, indicating that BIMI International Medical Inc. did not perform as well as the benchmark.


PeriodReturnBenchmark
Year-To-Date-23.29%10.16%
1 month-57.89%3.47%
6 months9.09%22.20%
1 year211.11%30.45%
5 years (annualized)-64.84%13.16%
10 years (annualized)-32.43%10.89%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
202426.26%39.96%
2023-30.00%-34.04%-8.92%36.36%12.31%

Risk-Adjusted Performance

Risk-Adjusted Performance Indicators

This table presents risk-adjusted performance metrics for BIMI International Medical Inc. (BIMI) and compares them with a selected benchmark (^GSPC). These performance indicators assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
BIMI
BIMI International Medical Inc.
1.56
^GSPC
S&P 500
2.79

Sharpe Ratio

The current BIMI International Medical Inc. Sharpe ratio is 1.56. A Sharpe ratio greater than 1.0 is considered acceptable.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.002.503.00OctoberNovemberDecember2024FebruaryMarch
1.56
2.79
BIMI (BIMI International Medical Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


BIMI International Medical Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%OctoberNovemberDecember2024FebruaryMarch
-99.99%
0
BIMI (BIMI International Medical Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the BIMI International Medical Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the BIMI International Medical Inc. was 100.00%, occurring on Mar 30, 2023. The portfolio has not yet recovered.

The current BIMI International Medical Inc. drawdown is 99.99%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-100%Jul 28, 20043749Mar 30, 2023

Volatility

Volatility Chart

The current BIMI International Medical Inc. volatility is 42.72%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%60.00%OctoberNovemberDecember2024FebruaryMarch
42.72%
2.80%
BIMI (BIMI International Medical Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of BIMI International Medical Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items